Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors

Oncogene volume 20, pages 1497–1508 (2001)Cite this article

Abstract

Telomeres are essential for cell survival and have been implicated in the mitotic control. The telomeric protein Pin2/TRF1 controls telomere elongation and its expression is tightly regulated during cell cycle. We previously reported that overexpression of Pin2/TRF1 affects mitotic progression. However, the role of Pin2/TRF1 at the interface between cell division and cell survival remains to be determined. Here we show that overexpression of Pin2 induced apoptosis in cells containing short telomeres, but not in cells with long telomeres. Furthermore, before entering apoptosis, Pin2-expressing cells first accumulated in mitosis and strongly stained with the mitosis-specific MPM2 antibody. Moreover, Pin2-induced apoptosis is potentiated by arresting cells in mitosis, but suppressed by accumulating cells in G1. In addition, overexpression of Pin2 also resulted in activation of caspase-3, and its proapoptotic activity was significantly reduced by inhibition of caspase-3. These results indicate that up-regulation of Pin2/TRF1 can specifically induce entry into mitosis and apoptosis, likely via a mechanism related to activation of caspase-3. Significantly, we also found that, out of 51 human breast cancer tissues and 10 normal controls examined, protein levels of Pin2/TRF1 in tumors were significantly lower than in normal tissues, as detected by immunoblotting analysis and immunocytochemistry. Since down-regulation of Pin2/TRF1 allows cells to maintain long telomeres, these results suggest that down-regulation of Pin2/TRF1 may be important for cancer cells to extend their proliferative potential.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 5
Figure 3
Figure 4
Figure 6
Figure 7

Similar content being viewed by others

References

  • Ahmad K, Golic KG . 1999 Genetics 151: 1041–1051

  • Aragona M, Buda CA, Panetta S, Morelli M, Giudice A, Campagna FL, Pontoriero A, Cascinu S, La Torre F . 2000 Oncol. Rep. 7: 987–990

  • Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw BA . 1996 Cell 86: 159–171

  • Beamish H, Khanna KK, Lavin MF . 1994 Radiat Res S130–S133

  • Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F, Lacombe F . 2000 Cytometry 40: 151–160

  • Chikashige Y, Ding DQ, Funabiki H, Haraguchi T, Mashiko S, Yanagida M, Hiraoka Y . 1994 Science 264: 270–273

  • Chong L, van SB, Broccoli D, Erdjument BH, Hanish J, Tempst P, de Lange T . 1995 Science 270: 1663–1667

  • Cooper JP, Nimmo ER, Allshire RC, Cech TR . 1997 Nature 385: 744–747

  • Cryns V, Yuan J . 1998 Genes Dev. 12: 1551–1570

  • Davis FM, Tsao TY, Fowler SK, Rao PN . 1983 Proc. Natl. Acad. Sci. USA 80: 2926–2930

  • Douglas RS, Pletcher Jr CH, Nowell PC, Moore JS . 1998 Cytometry 32: 57–65

  • Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P . 1996 Proc. Natl. Acad. Sci. USA 93: 13084–13089

  • Fu W, Begley JG, Killen MW, Mattson MP . 1999 J. Biol. Chem. 274: 7264–7271

  • Funabiki H, Hagan I, Uzawa S, Yanagida M . 1993 J. Cell Biol. 121: 961–976

  • Gavrieli Y, Sherman Y, Ben-Sasson SA . 1992 J. Cell. Biol. 119: 493–501

  • Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD . 1995 Cell 82: 823–829

  • Greider CW, Blackburn EH . 1996 Sci. Am. 274: 92–97

  • Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA . 1999 Nat. Med. 5: 1164–1170

  • Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR . 1999 Proc. Natl. Acad. Sci. USA. 96: 14276–14281

  • Ishibashi T, Lippard SJ . 1998 Proc. Natl. Acad. Sci. USA. 95: 4219–4223

  • Jakobisiak M, Bruno S, Skierski JS, Darzynkiewicz Z . 1991 Proc. Natl. Acad. Sci. USA. 88: 3628–3632

  • Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T . 1999 Science 283: 1321–1325

  • Keyomarsi K, Sandoval L, Band V, Pardee AB . 1991 Cancer Res. 51: 3602–3609

  • Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH . 1997 Science 275: 1478–1481

  • Kondo S, Kondo Y, Li G, Silverman RH, Cowell JK . 1998a Oncogene 16: 3323–3330

  • Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK, Barna BP . 1998b FASEB J. 12: 801–811

  • Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, Cowell JK . 1998c Oncogene 16: 2243–2248

  • Konig P, Giraldo R, Chapman L, Rhodes D . 1996 Cell 85: 125–136

  • Krauskopf A, Blackburn EH . 1996 Nature 383: 354–357

  • Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA . 1994 Genes Dev. 8: 1613–1626

  • Lee HW, Blasco MA, Gottlieb GJ, Horner JWN, Greider CW, DePinho RA . 1998 Nature 392: 569–574

  • Lu KP . 2000 Prog. Cell Cycle Res. 4: 83–96

  • Lu KP, Hanes SD, Hunter T . 1996 Nature 380: 544–547

  • Lu KP, Hunter T . 1995 Cell 81: 413–424

  • Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP . 1999a Nature 399: 784–788

  • Lu PJ, Zhou XZ, Shen M, Lu KP . 1999b Science 283: 1325–1328

  • Lundblad V . 2000 Mutat Res. 451: 227–240

  • Marcand S, Gilson E, Shore D . 1997 Science 275: 986–990

  • Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L, Westendorf JM . 1996 Mol. Biol. Cell 7: 1455–1469

  • Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin Jr AS . 1997 Science 278: 1812–1815

  • McEachern MJ, Blackburn EH . 1995 Nature 376: 403–409

  • Metcalfe JA, Parkhill J, Campbell L, Stacey M, Biggs P, Byrd PJ, Taylor AM . 1996 Nat. Genet. 13: 350–353

  • Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK . 1995 Nature 376: 37–43

  • Pandita TK, Pathak S, Geard CR . 1995 Cytogenet Cell Genet. 71: 86–93

  • Rudolph NS, Latt SA . 1989 Mutat Res. 211: 31–41

  • Sanchez Y, Desany BA, Jones WJ, Liu Q, Wang B, Elledge SJ . 1996 Science 271: 357–360

  • Sandell LL, Zakian VA . 1993 Cell 75: 729–739

  • Savitsky K, Bar SA, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanijali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jasper NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collin FC, Shiloh Y . 1995 Science 268: 1749–1753

  • Shen M, Haggblom C, Vogt M, Hunter T, Lu KP . 1997 Proc. Natl. Acad. Sci. USA 94: 13618–13623

  • Shen M, Stukenberg PT, Kirschner MW, Lu KP . 1998 Genes Dev. 12: 706–720

  • Smilenov LB, Morgan SE, Mellado W, Sawant SG, Kastan MB, Pandita TK . 1997 Oncogene 15: 2659–2665

  • van Steensel B, de Lange T . 1997 Nature 385: 740–743

  • Vandre DD, Davis FM, Rao PN, Borisy GG . 1986 Eur. J. Cell. Biol. 41: 72–81

  • Westendorf JM, Rao PN, Gerace L . 1994 Proc. Natl. Acad. Sci. USA 91: 714–718

  • Xia SJ, Shammas MA, Shmookler RJ . 1996 Mutat. Res. 364: 1–11

  • Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D . 1996 Gene. Dev. 10: 2411–2422

  • Xu Y, Baltimore D . 1996 Gene. Dev. 10: 2401–2410

  • Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP . 1997 Science 278: 1957–1960

  • Young AC, Chavez M, Giambernardi TA, Mattern V, McGill JR, Harris JM, Sarosdy MF, Patel P, Sakaguchi AY . 1997 Somat. Cell. Mol. Genet. 23: 275–286

  • Zakian VA . 1995 Science 270: 1601–1607

  • Zhang X, Mar V, Zhou W, Harrington L, Robinson MO . 1999 Genes. Dev. 13: 2388–2399

  • Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, Stoller G, Küllertz G, Stark M, Fischer G, Lu KP . 2000 Mol. Cell. 6: 873–883

  • Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E . 1993 Genes. Dev 1111–1125

  • Ziv Y, Jaspers NG, Etkin S, Danieli T, Trakhtenbrot L, Amiel A, Ravia Y, Shiloh Y . 1989 Cancer Res. 49: 2495–2501

Download references

Acknowledgements

We thank B Neel, L Cantley, J Yuan and Y Shiloh for constructive discussion, G Wulf for providing the human breast cancer tissues, T de Lange for long telomere HeLa cells, T Niu for helping statistical analysis and Y Shiloh for the A-T cell line. G Wulf and M Nakamura are a DOD Breast Cancer Program and a Human Frontier Research Program fellows, respectively. KP Lu is a Pew Scholar and a Lymphoma and Leukemia Society Scholar. The work was supported by grants from Nathan Shock Center on Aging and NIH (R01GM56230) to KP Lu.

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Cancer Biology Program, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, 02215, Massachusetts, MA, USA

    Shuji Kishi, Gerburg Wulf, Masafumi Nakamura & Kun Ping Lu

Authors
  1. Shuji Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerburg Wulf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masafumi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kun Ping Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishi, S., Wulf, G., Nakamura, M. et al. Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors. Oncogene 20, 1497–1508 (2001). https://doi.org/10.1038/sj.onc.1204229

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204229

Keywords

Search

Advanced search

Quick links